Home › Stock analysis › INAB
In8Bio (INAB) Stock: Why It's Up Today
Updated Oct 20, 2026, 4:00 PM ET · closing price
What changed since yesterday
- Closed at $1.14, +4.59% vs the prior close of $1.09.
- Volume 2.40K shares, 0.0x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
Compare with peers today
Moderna (MRNA)Amgen (AMGN)Gilead Sciences (GILD)Twist Bioscience (TWST)Revolution Medicines (RVMD)Argenx Se (ARGX)
INAB jumps 4.6% to $1.14. Closed at $1.14, +4.59% vs the prior close of $1.09. Day range $1.10–$1.17, opened at $1.10.
Last close$1.14+4.59%
Day range1.10–1.17
Open1.10
Volume2.40K
52-week range0.88–2.73
Avg volume (20d)49.86K
INAB daily analysis — what happened
A plain-English, data-only note for every US trading day (today's note updates every 2 hours while the market is open). Newest first; older days stay archived below.
Oct 20, 2026 — INAB jumps 4.6% to $1.14
- Closed at $1.14, +4.59% vs the prior close of $1.09. Day range $1.10–$1.17, opened at $1.10.
- Volume was 2.40K shares, 0.0x its 50-day average of 53.84K — lighter than usual.
- Price is -2.8% vs its 50-day average ($1.17) and -24.4% vs its 200-day average ($1.51).
- 52-week range $0.88–$2.73; today's close sits at 14% of that range, 58.2% below the 52-week high.
Oct 19, 2026 — INAB dips 1.8% to $1.09, 3 down days in a row
- Closed at $1.09, -1.80% vs the prior close of $1.11. Day range $1.07–$1.17, opened at $1.11.
- Volume was 21.50K shares, 0.4x its 50-day average of 54.14K — lighter than usual.
- Price is -6.8% vs its 50-day average ($1.17) and -28.0% vs its 200-day average ($1.51).
- 52-week range $0.88–$2.73; today's close sits at 11% of that range, 60.1% below the 52-week high.
- That makes 3 straight losses.
Oct 16, 2026 — INAB slides 6.3% to $1.11
- Closed at $1.11, -6.33% vs the prior close of $1.18. Day range $1.06–$1.18, opened at $1.17.
- Volume was 31.70K shares, 0.6x its 50-day average of 55.05K — lighter than usual.
- Price is -4.9% vs its 50-day average ($1.17) and -27.0% vs its 200-day average ($1.52).
- 52-week range $0.88–$2.73; today's close sits at 12% of that range, 59.3% below the 52-week high.
Oct 15, 2026 — INAB dips 1.3% to $1.18
- Closed at $1.18, -1.25% vs the prior close of $1.20. Day range $1.17–$1.24, opened at $1.21.
- Volume was 9.80K shares, 0.2x its 50-day average of 55.65K — lighter than usual.
- Price is +1.7% vs its 50-day average ($1.16) and -22.4% vs its 200-day average ($1.53).
- 52-week range $0.88–$2.73; today's close sits at 16% of that range, 56.6% below the 52-week high.
Oct 14, 2026 — INAB rises 1.7% to $1.20
- Closed at $1.20, +1.69% vs the prior close of $1.18. Day range $1.13–$1.23, opened at $1.18.
- Volume was 73.60K shares, 1.3x its 50-day average of 54.93K.
- Price is +3.4% vs its 50-day average ($1.16) and -21.6% vs its 200-day average ($1.53).
- 52-week range $0.88–$2.73; today's close sits at 17% of that range, 56.0% below the 52-week high.
Oct 13, 2026 — INAB slides 4.1% to $1.18, 4 down days in a row
- Closed at $1.18, -4.07% vs the prior close of $1.23. Day range $1.18–$1.26, opened at $1.25.
- Volume was 62.70K shares, 1.1x its 50-day average of 56.72K.
- Price is +2.1% vs its 50-day average ($1.16) and -23.2% vs its 200-day average ($1.54).
- 52-week range $0.88–$2.73; today's close sits at 16% of that range, 56.8% below the 52-week high.
- That makes 4 straight losses.
Oct 12, 2026 — INAB slides 8.2% to $1.23, 3 down days in a row
- Closed at $1.23, -8.21% vs the prior close of $1.34. Day range $1.23–$1.36, opened at $1.36.
- Volume was 31.80K shares, 0.6x its 50-day average of 57.23K — lighter than usual.
- Price is +6.8% vs its 50-day average ($1.15) and -20.2% vs its 200-day average ($1.54).
- 52-week range $0.88–$2.73; today's close sits at 19% of that range, 54.9% below the 52-week high.
- That makes 3 straight losses.
Oct 9, 2026 — INAB dips 2.9% to $1.34
- Closed at $1.34, -2.90% vs the prior close of $1.38. Day range $1.34–$1.38, opened at $1.36.
- Volume was 13.10K shares, 0.2x its 50-day average of 58.62K — lighter than usual.
- Price is +16.7% vs its 50-day average ($1.15) and -13.2% vs its 200-day average ($1.54).
- 52-week range $0.88–$2.73; today's close sits at 25% of that range, 50.9% below the 52-week high.
Oct 8, 2026 — INAB dips 1.4% to $1.38
- Closed at $1.38, -1.43% vs the prior close of $1.40. Day range $1.33–$1.40, opened at $1.40.
- Volume was 22.20K shares, 0.4x its 50-day average of 59.34K — lighter than usual.
- Price is +20.8% vs its 50-day average ($1.14) and -10.6% vs its 200-day average ($1.54).
- 52-week range $0.88–$2.73; today's close sits at 27% of that range, 49.5% below the 52-week high.
Oct 7, 2026 — INAB rises 0.7% to $1.40
- Closed at $1.40, +0.72% vs the prior close of $1.39. Day range $1.36–$1.41, opened at $1.38.
- Volume was 20.70K shares, 0.3x its 50-day average of 60.56K — lighter than usual.
- Price is +23.2% vs its 50-day average ($1.14) and -9.3% vs its 200-day average ($1.54).
- 52-week range $0.88–$2.73; today's close sits at 28% of that range, 48.7% below the 52-week high.
Oct 6, 2026 — INAB dips 2.1% to $1.39
- Closed at $1.39, -2.11% vs the prior close of $1.42. Day range $1.35–$1.45, opened at $1.42.
- Volume was 45.60K shares, 0.8x its 50-day average of 60.26K.
- Price is +22.9% vs its 50-day average ($1.13) and -9.9% vs its 200-day average ($1.54).
- 52-week range $0.88–$2.73; today's close sits at 28% of that range, 49.1% below the 52-week high.
Oct 5, 2026 — INAB rises 1.4% to $1.42, a 1-month high on 1.8x normal volume
- Closed at $1.42, +1.43% vs the prior close of $1.40. Day range $1.38–$1.45, opened at $1.43.
- Volume was 107.10K shares, 1.8x its 50-day average of 58.72K — unusually heavy trading.
- Price is +26.0% vs its 50-day average ($1.13) and -8.0% vs its 200-day average ($1.54).
- 52-week range $0.88–$2.73; today's close sits at 29% of that range, 48.0% below the 52-week high.
Oct 2, 2026 — INAB ends flat (+0.0%) to $1.40
- Closed at $1.40, +0.00% vs the prior close of $1.40. Day range $1.34–$1.46, opened at $1.42.
- Volume was 39.50K shares, 0.7x its 50-day average of 58.62K.
- Price is +24.7% vs its 50-day average ($1.12) and -9.3% vs its 200-day average ($1.54).
- 52-week range $0.88–$2.73; today's close sits at 28% of that range, 48.7% below the 52-week high.
INAB bull case vs bear case (from the data)
Bull case
- No clear positive signal in the price trend, filings or insider data right now.
Bear case
- Price is -2.8% vs its 50-day average — short-term trend is down.
- Price is -24.4% vs its 200-day average — below the long-term trend line.
- Latest fiscal-year net income: loss of $19.44M.
- Share count up 117.2% in a year (dilution).
- High volatility: average daily move of 3.2% over 20 sessions.
- Thin trading (under $2M a day on average) can mean wide bid/ask spreads.
INAB latest news & SEC filings
Every SEC filing by or about INAB in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Aug 13, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 7, 2026 · Form S-8 — Employee share plan registration
Registration of shares for employee stock plans (S-8)
Aug 6, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$4.78M (prior year -$5.09M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.25 (prior year -$1.24) (loss narrowed vs Jun 30, 2025)
Aug 6, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Things to know before you trade INAB
- Last results release: Aug 6, 2026 (8-K Item 2.02). Previous ones: May 7, 2026, Mar 12, 2026, Nov 6, 2025. Based on that rhythm, the next report is likely around Nov 5, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 3.24% (largest 8.2%). That is a volatile stock.
- Liquidity: about 49.86K shares (≈$56.84K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $1.14 vs a range of $0.88–$2.73 (14% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:30 on Jun 6, 2025
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 10-Q Aug 6, 2026; 8-K Aug 6, 2026; 8-K Jun 1, 2026.
- Share count: 9.86M shares outstanding (Aug 3, 2026), +117.2% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Biological Products, (No Diagnostic Substances).
INAB market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 20, 2026 | 1.10 | 1.17 | 1.10 | 1.14 | 2.40K |
| Oct 19, 2026 | 1.11 | 1.17 | 1.07 | 1.09 | 21.50K |
| Oct 16, 2026 | 1.17 | 1.18 | 1.06 | 1.11 | 31.70K |
| Oct 15, 2026 | 1.21 | 1.24 | 1.17 | 1.18 | 9.80K |
| Oct 14, 2026 | 1.18 | 1.23 | 1.13 | 1.20 | 73.60K |
| Oct 13, 2026 | 1.25 | 1.26 | 1.18 | 1.18 | 62.70K |
| Oct 12, 2026 | 1.36 | 1.36 | 1.23 | 1.23 | 31.80K |
| Oct 9, 2026 | 1.36 | 1.38 | 1.34 | 1.34 | 13.10K |
| Oct 8, 2026 | 1.40 | 1.40 | 1.33 | 1.38 | 22.20K |
| Oct 7, 2026 | 1.38 | 1.41 | 1.36 | 1.40 | 20.70K |
| Oct 6, 2026 | 1.42 | 1.45 | 1.35 | 1.39 | 45.60K |
| Oct 5, 2026 | 1.43 | 1.45 | 1.38 | 1.42 | 107.10K |
| Oct 2, 2026 | 1.42 | 1.46 | 1.34 | 1.40 | 39.50K |
| Oct 1, 2026 | 1.36 | 1.46 | 1.36 | 1.40 | 78.50K |
| Sep 30, 2026 | 1.31 | 1.36 | 1.31 | 1.33 | 30.30K |
| Sep 29, 2026 | 1.28 | 1.30 | 1.27 | 1.29 | 62.20K |
| Sep 28, 2026 | 1.19 | 1.30 | 1.19 | 1.24 | 74.30K |
| Sep 25, 2026 | 1.18 | 1.27 | 1.17 | 1.20 | 67.60K |
| Sep 24, 2026 | 1.11 | 1.25 | 1.10 | 1.19 | 180.00K |
| Sep 23, 2026 | 1.15 | 1.15 | 1.10 | 1.10 | 22.60K |
About In8Bio
In8Bio (INAB) is listed on the Nasdaq and classified by the SEC under “Biological Products, (No Diagnostic Substances)”. Its business address is in NEW YORK, NY. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1740279.
INAB board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Peter C. Brandt | Director | May 12, 2026 |
| Corinne Epperly | Director | May 12, 2026 |
| Emily Fairbairn | Director | May 29, 2026 |
| Jeremy R. Graff | Director | May 12, 2026 |
| Luba Greenwood | Director | May 12, 2026 |
| William Tai-Wei Ho | CEO | May 12, 2026 |
| Alan S. Roemer | Director | Dec 23, 2025 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| William Tai-Wei Ho | CEO | May 12, 2026 |
| Lawrence Lamb | EVP and CSO | May 12, 2026 |
| Patrick Mccall | CHIEF FINANCIAL OFFICER | May 12, 2026 |
| Kate Rochlin | President and COO | May 12, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
INAB financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-19.44M | -4.44 | $-12.71M |
| Dec 31, 2024 | — | $-30.44M | -17.05 | $-24.15M |
| Dec 31, 2023 | — | $-30.01M | -1.00 | $-23.34M |
| Dec 31, 2022 | — | $-28.52M | -1.36 | $-24.12M |
| Dec 31, 2021 | — | $-14.65M | -1.47 | $-13.51M |
Latest balance sheet: total assets $21.75M, total liabilities $3.38M, cash $— (as of Jun 30, 2026).
INAB earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 6, 2026 | 8-K Item 2.02 (results) | $0.97 |
| May 7, 2026 | 8-K Item 2.02 (results) | $1.60 |
| Mar 12, 2026 | 8-K Item 2.02 (results) | $1.91 |
| Nov 6, 2025 | 8-K Item 2.02 (results) | $1.66 |
| Aug 7, 2025 | 8-K Item 2.02 (results) | $2.15 |
| May 7, 2025 | 8-K Item 2.02 (results) | $4.95 |
| Mar 13, 2025 | 8-K Item 2.02 (results) | $6.78 |
| Nov 12, 2024 | 8-K Item 2.02 (results) | $10.50 |
| Aug 8, 2024 | 8-K Item 2.02 (results) | — |
| May 9, 2024 | 8-K Item 2.02 (results) | — |
| Mar 14, 2024 | 8-K Item 2.02 (results) | — |
| Nov 9, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Biological Products, (No Diagnostic Substances)
Moderna (MRNA)Amgen (AMGN)Gilead Sciences (GILD)Twist Bioscience (TWST)Revolution Medicines (RVMD)Argenx Se (ARGX)Kodiak Sciences (KOD)Biogen (BIIB)Halozyme Therapeutics (HALO)Vaxcyte (PCVX)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Space Exploration Technologies (SPCX)Tesla (TSLA)Sandisk (SNDK)Apple (AAPL)AMD (AMD)Microsoft (MSFT)Intel (INTC)Amazon (AMZN)
More on INAB
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 20, 2026, 4:00 PM ET. Filings: SEC EDGAR. Refreshed every 2 hours during US market hours.